← United States · Coverage record
US · SEC FORM 4
KalVista Pharmaceuticals, Inc.
KALV · — · CIK 0001348911 · Healthcare
INSIDER SIGNAL
No active buy signal
0 qualifying P purchase groups
in the current 180-day scoring window
31 Form 4 transaction lines observed in the same window
13 sales · 18 option, withholding, award, gift or other lines
Last qualifying purchase2025-04-09 · Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. · $235.5K
WHY NO ACTIVE SIGNAL?
Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
AprMayJunJulAugSepOct
Yea ChristopherCHIEF DEVELOPMENT OFFICER
○▼○○▼▼○▼○
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER
○▼○▼○▼○
Audhya Paul K.CHIEF MEDICAL OFFICER
○▼○○▼▼○
Sweeny NicoleChief Commercial Officer
○○▼▼○
Piekos BrianChief Financial Officer
○▼○
● Purchase▼ Sale○ Other
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
No recorded active-signal snapshot
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-04-09 · Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P..
Recent Form 4 activity
0Purchases
42Sales
49Other Form 4 lines
44SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING13 sale line(s) · context only
OTHER18 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-04-09 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 25,000 | USD 9.42 | USD 235,500 | SEC filing ↗ |
| 2025-02-13 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 61,700 | USD 9.33 | USD 575,661 | SEC filing ↗ |
| 2025-02-12 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 100,000 | USD 9.23 | USD 923,000 | SEC filing ↗ |
| 2025-02-11 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 26,703 | USD 9.18 | USD 245,134 | SEC filing ↗ |
| 2025-02-10 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 4,137 | USD 9.14 | USD 37,812 | SEC filing ↗ |
| 2025-02-07 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 73,649 | USD 9.29 | USD 684,199 | SEC filing ↗ |
| 2025-02-03 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 14,562 | USD 9.22 | USD 134,262 | SEC filing ↗ |
| 2025-01-31 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 11,754 | USD 8.89 | USD 104,493 | SEC filing ↗ |
| 2025-01-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 43,707 | USD 8.76 | USD 382,873 | SEC filing ↗ |
| 2024-02-08 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 29,747 | USD 14.70 | USD 437,281 | SEC filing ↗ |
| 2024-02-07 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 51,827 | USD 14.56 | USD 754,601 | SEC filing ↗ |
| 2024-02-06 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 4,474 | USD 14.74 | USD 65,947 | SEC filing ↗ |
| 2024-01-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 88,099 | USD 14.47 | USD 1,274,793 | SEC filing ↗ |
| 2024-01-29 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 80,600 | USD 14.22 | USD 1,146,132 | SEC filing ↗ |
| 2024-01-26 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | Purchase (P) | Common Stock | 4,174 | USD 12.98 | USD 54,179 | SEC filing ↗ |
Form 4 evidence
91 transaction lines in the latest 365-day window; 392 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Yea Christopher | D (D) | Common Stock | 229,918 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Sweeny Nicole | D (D) | Common Stock | 59,291 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Piekos Brian | D (D) | Common Stock | 21,661 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Yea Christopher | D (D) | Common Stock | 229,918 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Sweeny Nicole | D (D) | Common Stock | 59,291 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Piekos Brian | D (D) | Common Stock | 21,661 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Palleiko Benjamin L | D (D) | Common Stock | 479,989 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Audhya Paul K. | D (D) | Common Stock | 150,260 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-27 | Yea Christopher | Sale (S) | Common Stock | 33,800 | USD 26.78 | USD 905,164 | SEC filing ↗ |
| 2026-05-27 | Yea Christopher | Option exercise / conversion (M) | Common Stock | 33,800 | USD 7.07 | USD 238,966 | SEC filing ↗ |
| 2026-05-26 | Yea Christopher | Sale (S) | Common Stock | 1,966 | USD 26.78 | USD 52,649 | SEC filing ↗ |
| 2026-05-26 | Sweeny Nicole | Sale (S) | Common Stock | 1,489 | USD 26.78 | USD 39,875 | SEC filing ↗ |
| 2026-05-26 | Audhya Paul K. | Sale (S) | Common Stock | 2,239 | USD 26.78 | USD 59,960 | SEC filing ↗ |
| 2026-05-22 | Yea Christopher | Option exercise / conversion (M) | Common Stock | 3,125 | USD — | USD — | SEC filing ↗ |
| 2026-05-22 | Sweeny Nicole | Option exercise / conversion (M) | Common Stock | 5,000 | USD — | USD — | SEC filing ↗ |
| 2026-05-22 | Audhya Paul K. | Option exercise / conversion (M) | Common Stock | 5,000 | USD — | USD — | SEC filing ↗ |
| 2026-05-22 | Yea Christopher | Sale (S) | Common Stock | 2,358 | USD 26.78 | USD 63,147 | SEC filing ↗ |
| 2026-05-22 | Sweeny Nicole | Sale (S) | Common Stock | 1,861 | USD 26.78 | USD 49,838 | SEC filing ↗ |
| 2026-05-22 | Piekos Brian | Sale (S) | Common Stock | 1,489 | USD 26.78 | USD 39,875 | SEC filing ↗ |
| 2026-05-22 | Palleiko Benjamin L | Sale (S) | Common Stock | 10,926 | USD 26.78 | USD 292,598 | SEC filing ↗ |
| 2026-05-22 | Audhya Paul K. | Sale (S) | Common Stock | 2,685 | USD 26.78 | USD 71,904 | SEC filing ↗ |
| 2026-05-21 | Yea Christopher | Option exercise / conversion (M) | Common Stock | 3,750 | USD — | USD — | SEC filing ↗ |
| 2026-05-21 | Sweeny Nicole | Option exercise / conversion (M) | Common Stock | 6,250 | USD — | USD — | SEC filing ↗ |
| 2026-05-21 | Piekos Brian | Option exercise / conversion (M) | Common Stock | 5,000 | USD — | USD — | SEC filing ↗ |
| 2026-05-21 | Palleiko Benjamin L | Option exercise / conversion (M) | Common Stock | 23,250 | USD — | USD — | SEC filing ↗ |
| 2026-05-21 | Audhya Paul K. | Option exercise / conversion (M) | Common Stock | 6,250 | USD — | USD — | SEC filing ↗ |
| 2026-05-18 | Yea Christopher | Sale (S) | Common Stock | 1,108 | USD 26.76 | USD 29,650 | SEC filing ↗ |
| 2026-05-18 | Palleiko Benjamin L | Sale (S) | Common Stock | 1,129 | USD 26.76 | USD 30,212 | SEC filing ↗ |
| 2026-05-18 | Audhya Paul K. | Sale (S) | Common Stock | 1,032 | USD 26.76 | USD 27,616 | SEC filing ↗ |
| 2026-05-17 | Yea Christopher | Option exercise / conversion (M) | Common Stock | 1,774 | USD — | USD — | SEC filing ↗ |
| 2026-05-17 | Palleiko Benjamin L | Option exercise / conversion (M) | Common Stock | 2,419 | USD — | USD — | SEC filing ↗ |
| 2026-05-17 | Audhya Paul K. | Option exercise / conversion (M) | Common Stock | 2,419 | USD — | USD — | SEC filing ↗ |
| 2026-05-12 | Palleiko Benjamin L | Sale (S) | Common Stock | 3,322 | USD 26.71 | USD 88,731 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | KALV |
| CIK | 0001348911 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | — |
Data coverage
| Local Form 4 history | 392 transaction lines from 2020-02-05 to 2026-06-11 34 P purchase lines · 204 S sale lines · 154 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.